Cory Abate-Shen, PhD

Profile Headshot

Profile Navigation

Overview

Dr. Abate-Shen began her independent career as an Assistant Professor at Rutgers Medical School in 1991, where she rose quickly through the ranks, becoming Professor, Chief of the Division of Research in the Department of Medicine, and co-leader of the Prostate Program for The Cancer Institute of New Jersey. In 2007, Dr. Abate-Shen was recruited to the faculty of Columbia University Vagelos College of Physicians and Surgeons as the Michael and Stella Chernow Professor of Urological Oncology, at the Herbert Irving Comprehensive Cancer Center (HICCC), with appointments in the Departments of Urology, Pathology & Cell Biology, Medicine, Systems Biology, and the Institute of Cancer Genetics. In 2008, she was appointed Associate Director at the HICCC, and served as its Interim Director in 2012 as well as in 2017-2018. In 2019, she was appointed as Chair of the Department of Pharmacology, and the Robert Sonneborn Professor of Pharmacology at Columbia University Vagelos College of Physicians and Surgeons

Dr. Abate-Shen is an internationally-recognized leader in genitourinary malignancies. Her innovative studies of genetically-engineered mouse models for these cancers have led to the discovery of new biomarkers for early detection, as well as advances in cancer prevention and treatment. In recognition of her achievements, Dr. Abate-Shen has been the recipient of numerous awards, including a Sinsheimer Scholar Award, an NSF Young Investigator Award, and an American Cancer Society Research Professorship, the first to be awarded at Columbia University Medical Center. She has served on the Board of Scientific Counselors of the National Cancer Institute, as well as on its Blue Ribbon Panel Working Group for the Cancer Moonshot Initiative. Dr. Abate-Shen has served in various leadership roles in the American Association for Cancer Research including a member of its Board of Directors. Dr. Abate-Shen has also participated extensively in national grant review sections including as the chair of the NIH Molecular Oncology Study Section. Recently, she has been elected as a fellow of the American Association for the Advancement of Science.

Academic Appointments

  • Professor of Pharmacology and Robert Sonneborn Professor of Medicine
  • Professor of Urologic Sciences (in Urology)
  • Professor of Pathology and Cell Biology and of Systems Biology (in the Herbert Irving Comprehensive Cancer Center and the Institute for Cancer Genetics)
  • Chair, Department of Pharmacology

Research

Dr. Abate-Shen’s research focuses on the molecular mechanisms of cancer development. She has a longstanding commitment to the generation of mouse models of cancer and their effective use for translational research. Her major research interests are in the area of genitourological cancer. Most notably, her laboratory has developed novel models of prostate and bladder cancer, which have been utilized for investigating the molecular basis of the disease as well as preclinical models for evaluating new therapies.

Research Interests

  • Genitourinary cancer development
  • Molecular mechanisms of cancer development

Selected Publications

Selected Reviews and Commentaries

Complete List of Published Work

https://www.ncbi.nlm.nih.gov/myncbi/cory.abate-shen.1/bibliography/public/